Skip to main content

Motile Aeromonas Septicemia (MAS)

Site: EHC | Egyptian Health Council
Course: Aquatic animal medicine Guidelines
Book: Motile Aeromonas Septicemia (MAS)
Printed by: Guest user
Date: Tuesday, 24 December 2024, 1:59 AM

Description

"last update:9 June 2024"  

- Committee

We would like to acknowledge the committee of National Egyptian Guidelines for Veterinary Medical Interventions, Egyptian Health Council for adapting this guideline.

Executive Chief of the Egyptian Health Council: Prof. Dr Mohamed Mustafa Lotief.

Committee Chair: Prof. Ahmed M Byomi

The Rapporteur of the Committee: Prof. Dr Mohamed Mohamedy Ghanem.

Committee Members: Prof. Nabil yassien; Prof. Ashraf Aldesoky Shamaa; Prof. Amany Abbass; Prof. Dalia Mansour; Dr Essam Sobhy.

Authors: Mohamed Faisal1,2; Amany A. Abbass1 ; Adel A. Shaheen1; Amel M. El Asely1; Eman A. Abd El-Gawad1; Hiam S. Elabd1;​ Aya F. Matter1; Hadeer A. Youssef1, and  Amira M. El-Daim1.

1Department of Aquatic Animal Medicine, Faculty of Veterinary Medicine, Benha University, Egypt.

2College of Veterinary Medicine, Michigan State University, USA.

 


- Scope

Motile Aeromonas septicemia is a global problematic septicemic bacterial disease affecting freshwater and brackish water fishes as well as it has public health hazard. The bacterium causes a huge fish mortalities and significant economic losses in aquaculture. 


- Summary

Aeromoniasis was the most prevalent bacterial diseases affecting freshwater and brackish fishes caused by motile aeromonads of the Aeromonas hydrophila com­plex which includes Aeromonas hydrophila, Aeromonas sobria, and Aeromnas veronii. Aeromonas hydrophila is an opportunistic bacterium that can be transmitted to stressed fish by oral and dermal routes. The bacterium restricts fish production, harms the economy, and necessitates the use of costly control methods, making it a major barrier to the growth and sustainability of the aquaculture sector. The overuse of synthetic pharmaceuticals and antibiotics results in the emergence of drug bacterial resistant strains, as well as the buildup of drug residues in fish tissues and water that may be harmful for both the environment and humans. Moreover, there was no commercial vaccine against MAS. Therefore, to date control of MAS has been a challenging issue.


- Introduction

Motile Aeromonas Septicemia (MAS), hemorrhagic septicemia, ulcer disease, red-sore disease, or infectious dropsy are diseases that are caused by A. hydrophila complex (Mzula et al., 2019). The bacteria are normally inhabitant in the aquatic environment and the gastrointestinal tract of the healthy animal. Therefore, various motile aeromonads species are reported as stress related pathogen resulting in disease outbreaks and huge mortality in wild and cultured freshwater fishes (Youssuf et al., 2020). In addition, A. hydrophila has been reported in reptiles, amphibians, cattle, and humans worldwide.

The highest prevalence of aeromonas isolates from infected fishes that cause 80-100% modalities are reported to be A. hydrophila, A. jandei and A. veronii (Abdelsalam et al., 2021) Horizontal transmission via ingestion of contaminated food or direct contact with infected fish are the main route of MAS infection. Additionally, homologues co-infections of Aeromonas with other bacteria such as A jandaei and Averonii (Dong et al., 2017), or heterologous co-infection as Aeromonas sp. and Streptococcus sp (Sukenda et al., 2017), Averonii and Flavobacterium columnare (Dong et al., 2015), A. hydrophila and Tilapia Lake virus (Nicholson et al., 2020) are considered an important cause for enormous mortalities of tilapia farms.

In Egypt, Aeromonas species have been reported from Nile tilapia suffering from summer mortality syndromes (Matter et al., 2018; Youssuf et al., 2020).


- Etiological agent

▪️  The motile aeromonads are small Gram-negative bacilli or coccobacilli rods (~0.5 x 1µm) (fig 1), and non-spore-forming bacteria.


▪️  It can thrive and flourish in a wide range of temperatures, reaching as high as 37 ºC.

▪️  The virulence factors of A. hydrophila include haemolysin, aerolysin, cytosine, gelatinase, enterotoxin, and antimicrobial peptides.

▪️  MAS outbreaks are usually associated with environmental stressors that have diminished fish immunity to resist pathogen. These factors include temperature stress, stressful water quality conditions (low dissolved oxygen, high ammonia, high organic load, pollution), overcrowding, poor nutritional condition, physical injury, and infection with another bacteria, virus, parasites, or fungi (Harikrishnan & Balasundaram, 2005).


- Diagnosis

a-Clinical signs and lesions

▪️ The clinical signs vary from acute hemorrhagic septicemia to large ulcerative lesions in chronic stages depending on numerous factors such as virulence of the microorganism, fish immunity, and environmental stressors.


▪️ Typical signs of septicemia include reddened fins and anal opening, generalized skin hemorrhages, exophthalmia, abdominal distension, fin erosion, and protruded scales (lepidorthosis) due to accumulated fluids in the scale pockets (edema) (Fig 2) (Youssuf et al., 2020).

▪️ Chronic infections with Ahydrophila were associated with dermal ulcerative lesions with focal hemorrhages and inflammation.

➡️  Internally, hyperaemia of the internal organs and wall of swim-bladder, petechial haemorrhages on the liver, bloody to yellowish exudate in abdominal cavity, diffuse hemorrhages and congestion in the intestines and visceral organs, congestion of gills, grayish lesions in internal organs in chronic cases (Aly et al., 2023).

b- Laboratory diagnosis

▪️  Samples: Gills, intestine, and visceral organs of infected fish

I- Presumptive diagnosis

➡️Isolation and identification

▪️ It grows rapidly on common nutrient media such as Tryptic Soya Agar (TSA) or Brain Heart Infusion agar (BHIA) at 20 to 37°C producing creamy, round, slightly raised colonies that are commonly ∞-hemolytic on blood agar. On selective media such as Rimler Shotts agar it gives yellowish to green colonies (Shotts and Rimler, 1973).

▪️ The virulent bacterial strains are known to use myo-inositol as their only carbon source. They are also known to be oxidase positive, catalase positive, indole positive, ferment and oxidize glucose producing gas.

▪️ API 20E and API 20NE are commercial biochemical kits used for bacterial identification.

 II-Histopathological examination

▪️ Fish infected with Aeromonas spp revealed degenerative and necrotic changes in tissue with inflammatory response (Dong et al., 2017). Ahydrophila bacterium produces protease, elastase, and hemolysin that cause massive necrosis in the tissue (Yardimci and Aydin, 2011).

III-Confirmatory diagnosis

➡️ Molecular assay

▪️  PCR identification using sequence analysis of the 16S rRNA gene or the gyrB genes are the most common techniques for confirming the identity of motile aeromonad (El-Gohary et al. 2020).

▪️ Restriction fragment length polymorphism (RFLP)-PCR assay is also an easy technique that differentiate between the most relevant and antigenically related Aeromonas spp (Algammal et al., 2020)


- Control of disease

➡️  Preventive measures

▪️  A. hydrophia exhibits biochemical and serological heterogeneity, therefore, there are no commercial obtainable vaccines for MAS (Pridgeon and Klesius, 2012). However, researchers have developed vaccines from locally isolated strains such as live attenuated, formalin and autoclaved inactivated vaccine (Youssef et al., 2023), lipopolysaccharide vaccine (Dehghani et al., 2012) that showing promise protection against MAS.

▪️  Preventive measures against MAS involve improving aquaculture management to reduce stress, tissue injuries, and prevention of parasites and other infectious agents. Effective treatment should start once a fish infection with A. hydrophila is confirmed (Swann and White 1991). Applications of bacteriophages against MAS have been reported in striped catfish (Le et al., 2018) and tilapia (El-Araby et al., 2016).

▪️  Many herbal immunostimulants, probiotics and prebiotics have been improved fish immune system and resistance against aeromonas infection (Abd El-latif et al., 2021)

➡️  Treatment

▪️ Appropriate application of antibiotics is important to treat pathogenic bacteria and minimize the development of antibiotic resistance in aquaculture. Therefore, antibiotics should only be used when the fish still feeding well, and the medicated diets must be regularly administered at the therapeutic dose for the duration of the prescribed treatment period.

▪️  A. hydrophila strains have been developed Multiple antibiotic resistance (MAR) worldwide (Vivekanandhan et al., 2002).

▪️  There are three feed-based treatments available against MAS, Terramycin® (oxytetracycline), Romet 30® (sulfadimethoxine plus ormetoprim), and Aquaflor® (florfenicol). The U.S. Food and Drug Administration has only approved Terramycin® for treatment against Aeromonas in salmonids and catfish.

➡️ Zoonotic importance

▪️ A. hydrophila is a food-borne pathogen, has zoonotic importance and can be transmitted to humans via consumption of contaminated water and raw or uncooked infected aquatic products (Yousr et al., 2007)

▪️  Infection with A. hydrophila can result in gastrointestinal infection (watery diarrhea to dysenteric or bloody diarrhea) or non-gastrointestinal complications (hemolytic syndrome and kidney disease, bacteremia and septicemia, cellulitis, meningitis, ocular infections, pneumonia, urinary tract infection in neonates, osteomyelitis, peritonitis and acute cholecystitis (Borger et al., 2006).

  

- References

Abd El-latif, A.M., Abd El-Gawad, E. A., Soror E. I., Shourbela R. M., Zahran E. (2021).  Dietary supplementation with miswak (Salvadora persica) improves the health status of Nile tilapia and protects against Aeromonas hydrophila infection. Aquaculture Report, 19,100594.

Abdelsalam M, Ewiss MAZ, Khalefa HS, Mahmoud MA, Elgendy MY, Abdel-Moneam DA. (2021) Coinfections of Aeromonas spp., Enterococcus faecalis, and Vibrio alginolyticus isolated from farmed Nile tilapia and African catfish in Egypt, with an emphasis on poor water quality. Microb Pathog, 160:105213.

Algammal AM, Mohamed MF, Tawfiek BA, Hozzein WN, El Kazzaz WM, Mabrok M. (2020). Molecular Typing, Antibiogram and PCR-RFLP Based Detection of Aeromonas hydrophila Complex Isolated from Oreochromis niloticus. Pathogens, 9(3):238.

Aly, S.M., Abou-El-Atta, M.E., El-Mahallawy, H.S. et al. (2023) Aeromonas veronii and ulcerative syndrome in cultured Nile tilapia (Oreochromis niloticus) and their associated factors. Aquacult Int 31, 2867–2881.

Borger van der Burg, B. L., Bronkhorst, M. W., & Pahlplatz, P. V. (2006). Aeromonas hydrophila necrotizing fasciitis. A case report. The Journal of Bone and Joint Surgery.American Volume, 88(6), 1357-1360.

Dehghani S, Akhlaghi M, Dehghani M. (2012). Efficacy of formalin-killed, heat-killed, and lipopolysaccharide vaccines against motile aeromonads infection in rainbow trout (Oncorhynchus mykissGlobal Veterinaria;9:409–415.

Dong HT, Nguyen VV, Le HD, et al. (2015). Naturally concurrent infections of bacterial and viral pathogens in disease outbreaks in cultured Nile tilapia (Oreochromis niloticus) farms. Aquaculture, 448: 427-435.

Dong HT, Techatanakitarnan C, Jindakittikul P, et al. (2017). Aeromonas jandaei and Aeromonas veronii caused disease and mortality in Nile tilapia, Oreochromis niloticus (L.). J Fish Dis. 40(10): 1395-1403.

El-Araby, D.; El-Didamony, G.; Megahed, M. (2016). New approach to use phage therapy against Aeromonas hydrophila induced Motile Aeromonas Septicemia in nile tilapia. J. Mar. Sci. Res. Dev. 6 (3); 1000194

El-Gohary FA, Zahran E, Abd El-Gawad EA, El-Gohary AH, Abdelhamid FM, El-Mleeh A, Elmahallawy EK and Elsayed MM. (2020). Investigation of the Prevalence, Virulence Genes, and Antibiogram of Motile Aeromonads Isolated from Nile Tilapia Fish Farms in Egypt and Assessment of their Water Quality. Animals: 10(8), 1432.

Harikrishnan R., Balasundaram C. (2005) Modern trends in Aeromonas hydrophila disease management with fish. Rev. Fish. Sci., 13(4):281–320.

Le, T.S.; Nguyen, T.H.; Vo, H.P.; Doan, V.C.; Nguyen, H.L.; Tran, M.T.; Tran, T.T.; Southgate, P.C.; Kurtböke, D.İ. (2018). Protective Effects of Bacteriophages against Aeromonas hydrophila Causing Motile Aeromonas Septicemia (MAS) in Striped Catfish. Antibiotics , 7, 16.

Martinez-Murcia A.J., Saavedra M.J., Mota V.R., Maier T., Stackebrandt E., Cousin S. (2008). Aeromonas aquariorum sp. nov., isolated from aquaria of ornamental fish. Int. J. Syst. Evol. Microbiol; 58(5):1169–1175.

Matter A., El-Asely A., Shaheen A.A, Abdel Gawad E., Elabd H., Abbass A. (2018). Phenotypic and molecular characterization of bacterial pathogens isolated from diseases freshwater fishes. International Journal of Fisheries and Aquatic studies 6(2), 34-41.

Mzula A, Wambura PN, Mdegela RH, Shirima GM. (2019) Phenotypic and molecular detection of Aeromonads infection in farmed Nile tilapia in Southern highland and Northern Tanzania. Heliyon, 5(8):e02220. 

Nicholson P, Mon-on N, Jaemwimol P, Tattiyapong P, Surachetpong W. 2020. Coinfection of tilapia lake virus and Aeromonas hydrophila synergistically increased mortality and worsened the disease severity in tilapia (Oreochromis spp.). Aquaculture, 520:734746.

Parthasarathy R., Ravi D. (2011). Probiotic bacteria as growth promoter and biocontrol agent against Aeromonas hydrophila in Catla catla (Hamilton, 1822) Indian J. Fish;58(3):87–93.

Pridgeon, J.W.; Klesius, P.H. (2012) Major bacterial diseases in aquaculture and their vaccine development. CAB Rev.7, 1–16. 

Shotts, E. B., Jr., and R. Rimler. 1973. Medium for the isolation of Aeromonas hydrophila. Applied Microbiology 26:550-553

Soler, L., M. A. Yanez, M. R. Chacon, M. G. Aguilera-Arreola, V. Catalan, M. J. Figueras, and A. J. Martinez-Murcia. 2004. Phylogenetic analysis of the genus Aeromonas based on two housekeeping genes. International Journal of Systematic and Evolutionary Microbiology 54: 1511-1519.

Sukenda S, Sumiati T, Nuryati S, Lusiastuti AM, Hidayatullah D. 2017. Specific immune response kinetics and mortality patterns of tilapia Oreochromis niloticus on post-cocktail vaccination period against the infection of Aeromonas hydrophila and Streptococcus agalactiae. Omni-Akuatika, 13(2): 6-15.

Yardimci B., Aydin Y. (2011).  Pathological findings of experimental Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus). Ankara Univ. Vet. Fak. Derg., 58 (2011), pp. 47-54

Youssef HA, Ayoub HF, Soror EI, Matter AF. 2023. Virulence genes contributing to Aeromonas veronii pathogenicity in Nile tilapia (Oreochromis niloticus): approaching the development of live and inactivated vaccines. Aquac Int.;31(3):1253-1267. 

Youssuf H, Abdel Gawad EA, El Asely AM, Elabd H, Matter AF, Shaheen AA, Abbass AA. 2020. Insight into summer mortalities syndrome in farmed Nile tilapia (Oreochromis niloticus) associated with bacterial infections. Benha Veterinary Medical Journal 39; 111-118.